Steve Skolsky is senior vice president and global head of Site Management at Quintiles. In this role, Skolsky leads a group of more than 5,000 employees globally who are at the core of the company’s Clinical Development organization - monitoring clinical conduct at research sites as well as collecting and managing data from patients in clinical trials around the world.
Before joining Quintiles, this 30-year veteran of the biopharmaceutical industry was most recently principal at EXPIS Partners, a strategic life science consultancy and vice chairman of the board of Basilea Pharmaceutica. He also previously held the posts of president and CEO of Sequoia Pharmaceuticals and CEO of Trimeris, Inc. These positions followed some 20 years at GlaxoSmithKline (GSK) in a range of senior leadership roles, including senior vice president of Global Clinical Development and Product Strategy and managing director of GSK’s operations in Australia and New Zealand. He is a current Board Director for Basilea Pharmaceutica and is a member of the Board of Directors for Adherex Technologies.
Skolsky earned his Bachelor of Arts degree in Biology from the University of North Carolina at Chapel Hill.